|
Name |
periconicin A
|
Molecular Formula | C20H28O3 | |
IUPAC Name* |
(1S,3R,4S,5S,7R,8E)-5-hydroxy-1,4-dimethyl-6-oxo-12-propan-2-yltricyclo[9.3.0.03,7]tetradeca-8,11-diene-8-carbaldehyde
|
|
SMILES |
C[C@H]1[C@H]2C[C@@]3(CCC(=C3C/C=C(\[C@@H]2C(=O)[C@H]1O)/C=O)C(C)C)C
|
|
InChI |
InChI=1S/C20H28O3/c1-11(2)14-7-8-20(4)9-15-12(3)18(22)19(23)17(15)13(10-21)5-6-16(14)20/h5,10-12,15,17-18,22H,6-9H2,1-4H3/b13-5-/t12-,15+,17-,18-,20-/m0/s1
|
|
InChIKey |
IUXNFOSJQWRNNO-ZFOLLOEKSA-N
|
|
Synonyms |
periconicin A; (1S,3R,4S,5S,7R,8E)-5-hydroxy-1,4-dimethyl-6-oxo-12-propan-2-yltricyclo[9.3.0.03,7]tetradeca-8,11-diene-8-carbaldehyde; CHEMBL465544; CHEBI:185839; LMPR0104350002
|
|
CAS | NA | |
PubChem CID | 10471036 | |
ChEMBL ID | CHEMBL465544 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 316.4 | ALogp: | 3.0 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 54.4 | Aromatic Rings: | 3 |
Heavy Atoms: | 23 | QED Weighted: | 0.613 |
Caco-2 Permeability: | -4.717 | MDCK Permeability: | 0.00002950 |
Pgp-inhibitor: | 0.416 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.057 |
Blood-Brain-Barrier Penetration (BBB): | 0.935 | Plasma Protein Binding (PPB): | 84.28% |
Volume Distribution (VD): | 1.599 | Fu: | 3.96% |
CYP1A2-inhibitor: | 0.05 | CYP1A2-substrate: | 0.638 |
CYP2C19-inhibitor: | 0.139 | CYP2C19-substrate: | 0.849 |
CYP2C9-inhibitor: | 0.142 | CYP2C9-substrate: | 0.057 |
CYP2D6-inhibitor: | 0.163 | CYP2D6-substrate: | 0.093 |
CYP3A4-inhibitor: | 0.914 | CYP3A4-substrate: | 0.734 |
Clearance (CL): | 9.239 | Half-life (T1/2): | 0.085 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.122 |
Drug-inuced Liver Injury (DILI): | 0.344 | AMES Toxicity: | 0.03 |
Rat Oral Acute Toxicity: | 0.162 | Maximum Recommended Daily Dose: | 0.806 |
Skin Sensitization: | 0.69 | Carcinogencity: | 0.222 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.033 |
Respiratory Toxicity: | 0.782 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004252 | 0.814 | D04SFH | 0.262 | ||||
ENC006039 | 0.416 | D0D2TN | 0.239 | ||||
ENC002981 | 0.321 | D0I2SD | 0.238 | ||||
ENC003251 | 0.320 | D01CKY | 0.236 | ||||
ENC003783 | 0.314 | D0G8BV | 0.235 | ||||
ENC002000 | 0.314 | D0K0EK | 0.235 | ||||
ENC003777 | 0.312 | D0K7LU | 0.233 | ||||
ENC002982 | 0.311 | D0I1LH | 0.229 | ||||
ENC003687 | 0.295 | D0P0HT | 0.229 | ||||
ENC001559 | 0.294 | D08PIQ | 0.227 |